Caligiuri, M A <br/><br/>
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.  [electronic resource] 

 -  The Journal of clinical investigation  Jan 1993 
 - 123-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI116161  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibody-Dependent Cell Cytotoxicity--drug effects<br/>Antigens, CD--analysis<br/>Antigens, Differentiation, T-Lymphocyte--analysis<br/>CD56 Antigen<br/>Humans<br/>Infusions, Intravenous<br/>Interleukin-2--administration & dosage<br/>Killer Cells, Natural--drug effects<br/>Neoplasms--blood<br/>Receptors, Interleukin-2--analysis<br/>Recombinant Proteins--administration & dosage<br/>Time Factors